Table of contents

Clinical and epidemiological research

• Extended report: Smoking and risk of incident psoriatic arthritis in US women (8 November, 2011) Free

  Wenqing Li, Jiali Han, Abrar A Qureshi
• Extended report: Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort (11 October, 2011) Free

  Ho Yin Chung, Pedro Machado, Désirée van der Heijde, Maria-Antonietta D'Agostino, Maxime Dougados
• Extended report: Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study (25 November, 2011)

  Yoshiya Tanaka, Masayoshi Harigai, Tsutomu Takeuchi, Hisashi Yamanaka, Naoki Ishiguro, Kazuhiko Yamamoto, Nobuyuki Miyasaka, Takao Koike, Minoru Kanazawa, Takuya Oba, Toru Yoshinari, Daniel Baker
• Extended report: Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden (29 November, 2011)

  Lisbeth Ärlestig, Mohammed Mullazehi, Heidi Kokkonen, Joacim Rocklöv, Johan Rönnelid, Solbritt Rantapää Dahlqvist
• Extended report: Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet (29 November, 2011)

  Marije F Bakker, Johannes WG Jacobs, Aike A Kruize, Maaike J van der Veen, Catharina van Booma-Frankfort, Simone A Vreugdenhil, Johannes WJ Bijlsma, Floris PJG Lafeber, Paco MJ Welsing
• Extended report: The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review (29 November, 2011)

  Claire Bombardier, Marco Barbieri, Anju Parthan, Debra J Zack, Valery Walker, David Macarios, Josef S Smolen
• Extended report: A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry (30 December, 2011)

  Lydia G Schipper, Marloes Vermeer, Hillechiena H Kuper, Monique O Hoekstra, Cees J Haagsma, Alfons A Den Broeder, Piet van Riel, Jaap Fransen, Mart AFJ van de Laar
• Extended report: Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP (1 February, 2012)

  Merete Lund Hetland, Mikkel Østergaard, Bo Ejbjerg, Søren Jacobsen, Kristian Stengaard-Pedersen, Peter Junker, Tine Lottenburger, Ib Hansen, Lis Smedegaard Andersen, Ulrik Tarp, Anders Svendsen, Jens Kristian Pedersen, Henrik Skjødt, Torkell Ellingsen, Hanne Lindegaard, Jan Pødenphant, Kim Hørslev-Petersen, CIMESTRA study group
• Extended report: Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study (2 February, 2012)

  Edward Clark Keystone, Joel M Kremer, Anthony Russell, Jane Box, Carlos Abud-Mendoza, Mario Garza Elizondo, Allison Luo, Richard Aranda, Ingrid Delaet, Rene Swanink, Sheila Gujrathi, Michael Luggen
• Extended report: Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis (20 January, 2012)

  Claire Immediato Daïen, Yohan Duny, Thomas Barnetche, Jean-Pierre Daurès, Bernard Combe, Jacques Morel
• Extended report: The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register (12 January, 2012)

  Louise K Mercer, Adele C Green, James B Galloway, Rebecca Davies, Mark Lunt, William G Dixon, Kath D Watson, British Society for Rheumatology Biologics Register Control Centre Consortium, Deborah PM Symmons, Kimme L Hyrich
• Extended report: Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab (25 February, 2012)

  A Ruyssen-Witrand, S Rouanet, B Combe, M Dougados, X Le Loët, J Sibilia, J Tebib, X Mariette, A Constantin
• Extended report: Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study (29 November, 2011)

  Jürgen Braun, Xenofon Baraliakos, Kay-Geert A Hermann, Désirée van der Heijde, Robert D Inman, Atul A Deodhar, Anna Baratelle, Stephen Xu, Weichun Xu, Benjamin Hsu
• Extended report: Association between the IL-1 family gene cluster and spondyloarthritis (6 February, 2012)

  Dominique Monnet, Amir Kadi, Brigitte Izac, Nicolas Lebrun, Franck Letourneur, Elena Zinovieva, Roula Said-Nahal, Gilles Chiocchia, Maxime Breban
• Extended report: Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification (29 November, 2011)

  Gust Verbruggen, Ruth Wittoek, Bert Vander Cruyssen, Dirk Elewaut
• Extended report: Associations between MRI-defined synovitis, bone marrow lesions and structural features and measures of pain and physical function in hand osteoarthritis (25 November, 2011)

  Ida Kristin Haugen, Pernille Bøyesen, Barbara Slatkowsky-Christensen, Sølve Sesseng, Désirée van der Heijde, Tore K Kvien
• Extended report: Development of radiological knee osteoarthritis in patients with knee complaints (29 November, 2011)

  B M de Klerk, S Willemsen, D Schiphof, J B J van Meurs, B W Koes, A Hofman, S M A Bierma-Zeinstra
• Extended report: A mindfulness-based group intervention to reduce psychological distress and fatigue in patients with inflammatory rheumatic joint diseases: a randomised controlled trial (20 December, 2011)

  Heidi A Zangi, Petter Mowinckel, Arnstein Finset, Liv R Eriksson, Turid Ø Høystad, Anne Kristine Lunde, Kåre B Hagen
• Extended report: Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy (30 January, 2012)

  Arsenio Spinillo, Fausta Beneventi, Véronique Ramoni, Roberto Caporali, Elena Locatelli, Margherita Simonetta, Chiara Cavagnoli, Claudia Alpini, Giulia Albonico, Elena Prisco, Carlomaurizio Montecucco
• Extended report: Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study (15 December, 2011)

  Gim Gee Teng, Li-Wei Ang, Kenneth G Saag, Mimi C Yu, Jian-Min Yuan, Woon-Puay Koh
• Extended report: Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial (23 January, 2012)

  Nicola Dalbeth, Ruth Ames, Greg D Gamble, Anne Horne, Sumwai Wong, Barbara Kuhn-Sherlock, Alastair MacGibbon, Fiona M McQueen, Ian R Reid, Kate Palmano
• Extended report: Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial (31 January, 2012)

  Michael Spaeth, Robert M Bennett, Beverly A Benson, Y Grace Wang, Chinglin Lai, Ernest H Choy
• Extended report: Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica (5 January, 2012)

  N T Baerlecken, A Linnemann, W L Gross, F Moosig, T R Vazquez-Rodriguez, M A Gonzalez-Gay, J Martin, I Kötter, J C Henes, I Melchers, P Vaith, R E Schmidt, T Witte
• Extended report: Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study (15 December, 2011)

  Marloes W Heijstek, Pieter GM van Gageldonk, Guy AM Berbers, Nico M Wulffraat
• Extended report: Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up (29 November, 2011)

  Lorraine Harper, Matthew D Morgan, Michael Walsh, Peter Hoglund, Kerstin Westman, Oliver Flossmann, Vladimir Tesar, Phillipe Vanhille, Kirsten de Groot, Raashid Luqmani, Luis Felipe Flores-Suarez, Richard Watts, Charles Pusey, Annette Bruchfeld, Niels Rasmussen, Daniel Blockmans, Caroline O Savage, David Jayne
• Extended report: Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study (20 December, 2011)

  H Chinoy, S Adimulam, F Marriage, P New, M Vincze, E Zilahi, A Kapitány, A Gyetvai, L Ekholm, P Novota, M Remakova, P Charles, N J McHugh, L Padyukov, L Alfredsson, J Vencovsky, I E Lundberg, K Danko, W E Ollier, R G Cooper
• Extended report: Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis (29 November, 2011)

  Suzanne Arends, Cecile Grootscholten, Ronald HWM Derksen, Stefan P Berger, Ruud GL de Sévaux, Alexandre E Voskuyl, Marc Bijl, Jo HM Berden
• Extended report: The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis (20 January, 2012)

  Dirk Holzinger, Michael Frosch, Astrid Kastrup, Femke H M Prince, Marieke H Otten, Lisette W A Van Suijlekom-Smit, Rebecca ten Cate, Esther P A H Hoppenreijs, Sandra Hansmann, Halima Moncrieffe, Simona Ursu, Lucy R Wedderburn, Johannes Roth, Dirk Foell, Helmut Wittkowski
• Extended report: Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjögren's syndrome in Scandinavian samples (30 January, 2012)

  Anne Isine Bolstad, Stephanie Le Hellard, Gudlaug Kristjansdottir, Lilian Vasaitis, Marika Kvarnström, Christopher Sjöwall, Svein Joar Auglænd Johnsen, Per Eriksson, Roald Omdal, Johan G Brun, Marie Wahren-Herlenius, Elke Theander, Ann-Christine Syvänen, Lars Rönnblom, Gunnel Nordmark, Roland Jonsson
• Concise report: Combination etanercept and methotrexate provides better disease control in very early (≤4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study (8 March, 2012)

  Paul Emery, Tore K Kvien, Bernard Combe, Bruce Freundlich, Deborah Robertson, Tahmina Ferdousi, Eustratios Bananis, Ronald Pedersen, Andrew S Koenig
• Concise report: Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays (30 January, 2012)

  Moises Labrador-Horrillo, Maria Angeles Martínez, Albert Selva-O'Callaghan, Ernesto Trallero-Araguás, Eva Balada, Miquel Vilardell-Tarrés, Candido Juarez
• Concise report: Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients (30 January, 2012)

  Sophie Martin Du Pan, Almut Scherer, Cem Gabay, Axel Finckh
• Concise report: Endogenous parathyroid hormone is associated with reduced cartilage volume in vivo in a population-based sample of adult women (21 February, 2012)

  Sharon Lee Brennan, Flavia M Cicuttini, Geoff C Nicholson, Julie A Pasco, Mark A Kotowicz, Anita E Wluka